Ocular Therapeutix (OCUL) Change in Account Payables (2013 - 2026)
Ocular Therapeutix's quarterly Change in Account Payables came in at $3.7 million in Q1 2026, up 53028.57% year-on-year from N/an in Q1 2025, and up 374.87% quarter-over-quarter from -$1.4 million in Q4 2025.
Ocular Therapeutix has reported Change in Account Payables for 14 years, with the latest figure at $3.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 53028.57% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 240.97% YoY), and the FY2025 full-year result was -$887000.0, down 178.93% from the prior year.
- Change in Account Payables for Q1 2026 stood at $3.7 million, up from -$1.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.7 million in Q1 2026, with the low at -$2.4 million in Q2 2024.
- Average Change in Account Payables over 5 years is $145647.1, with a median of $247000.0 recorded in 2023.
- Year-over-year, Change in Account Payables tumbled 1308.04% in 2025 and soared 53028.57% in 2026.
- Tracing OCUL's Change in Account Payables over 5 years: stood at -$1.1 million in 2022, then soared by 158.47% to $656000.0 in 2023, then plunged by 82.93% to $112000.0 in 2024, then plunged by 1308.04% to -$1.4 million in 2025, then jumped by 374.87% to $3.7 million in 2026.
- The last three Change in Account Payables figures came in at $3.7 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 3.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Jun 30, 2024 | -2.42 Mn |
| Jun 30, 2024 | -2.42 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 656,000.00 |
| Dec 31, 2023 | 656,000.00 |
| Sep 30, 2023 | 247,000.00 |
| Sep 30, 2023 | 247,000.00 |
| Jun 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -1.35 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | -1.12 Mn |
| Dec 31, 2022 | -1.12 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 304,000.00 |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | -1.11 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Dec 31, 2021 | 366,000.00 |
| Dec 31, 2021 | 366,000.00 |
| Sep 30, 2021 | 175,000.00 |
| Sep 30, 2021 | 175,000.00 |
| Jun 30, 2021 | -268,000.00 |
| Jun 30, 2021 | -268,000.00 |
| Mar 31, 2021 | 1.52 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | -565,000.00 |
| Dec 31, 2020 | -565,000.00 |
| Sep 30, 2020 | 899,000.00 |
| Sep 30, 2020 | 899,000.00 |
| Jun 30, 2020 | -550,000.00 |
| Jun 30, 2020 | -550,000.00 |
| Mar 31, 2020 | -236,000.00 |
| Mar 31, 2020 | -236,000.00 |
| Dec 31, 2019 | 92,000.00 |
| Dec 31, 2019 | 92,000.00 |
| Sep 30, 2019 | -742,000.00 |
| Sep 30, 2019 | -742,000.00 |
| Jun 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 13,000.00 |
| Mar 31, 2019 | 761,000.00 |
| Mar 31, 2019 | 761,000.00 |
| Dec 31, 2018 | 207,000.00 |
| Dec 31, 2018 | 207,000.00 |
| Sep 30, 2018 | 536,000.00 |
| Sep 30, 2018 | 536,000.00 |
| Jun 30, 2018 | -877,000.00 |
| Jun 30, 2018 | -877,000.00 |
| Mar 31, 2018 | -662,000.00 |
| Mar 31, 2018 | -662,000.00 |
| Dec 31, 2017 | 769,000.00 |
| Dec 31, 2017 | 769,000.00 |
| Sep 30, 2017 | -2.76 Mn |
| Sep 30, 2017 | -2.76 Mn |
| Jun 30, 2017 | 2.26 Mn |
| Jun 30, 2017 | 2.26 Mn |
| Mar 31, 2017 | 659,000.00 |
| Mar 31, 2017 | 659,000.00 |
| Dec 31, 2016 | 130,000.00 |
| Dec 31, 2016 | 130,000.00 |
| Sep 30, 2016 | 173,000.00 |
| Sep 30, 2016 | 173,000.00 |
| Jun 30, 2016 | -541,000.00 |
| Jun 30, 2016 | -541,000.00 |
| Mar 31, 2016 | 79,000.00 |
| Mar 31, 2016 | 79,000.00 |
| Dec 31, 2015 | 708,000.00 |
| Dec 31, 2015 | 708,000.00 |
| Sep 30, 2015 | -1.01 Mn |
| Sep 30, 2015 | -1.01 Mn |
| Jun 30, 2015 | 498,000.00 |
| Jun 30, 2015 | 498,000.00 |
| Mar 31, 2015 | 153,000.00 |
| Mar 31, 2015 | 153,000.00 |
| Dec 31, 2014 | 444,000.00 |
| Dec 31, 2014 | 444,000.00 |
| Sep 30, 2014 | -282,000.00 |
| Sep 30, 2014 | -282,000.00 |
| Jun 30, 2014 | 41,000.00 |
| Jun 30, 2014 | 41,000.00 |
| Mar 31, 2014 | 304,000.00 |
| Mar 31, 2014 | 304,000.00 |
| Dec 31, 2013 | -257,000.00 |
| Dec 31, 2013 | -257,000.00 |
| Sep 30, 2013 | 179,000.00 |
| Sep 30, 2013 | 179,000.00 |